Manufacture of Clinical-Grade CD19-Specific T Cells Stably Expressing Chimeric Antigen Receptor Using Sleeping Beauty System and Artificial Antigen Presenting Cells

Adoptive transfer of T cells expressing a CD19-specific chimeric antigen receptor (CAR) is being evaluated in multiple clinical trials. Our current approach to adoptive immunotherapy is based on a second generation CAR (designated CD19RCD28) that signals through a CD28 and CD3-ζ endodomain. T cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Harjeet, Figliola, Matthew J., Dawson, Margaret J., Olivares, Simon, Zhang, Ling, Yang, Ge, Maiti, Sourindra, Manuri, Pallavi, Senyukov, Vladimir, Jena, Bipulendu, Kebriaei, Partow, Champlin, Richard E., Huls, Helen, Cooper, Laurence J. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669363/
https://www.ncbi.nlm.nih.gov/pubmed/23741305
http://dx.doi.org/10.1371/journal.pone.0064138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669363/
https://www.ncbi.nlm.nih.gov/pubmed/23741305
http://dx.doi.org/10.1371/journal.pone.0064138

Ejemplares similares